NCT05388461 Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy
| NCT ID | NCT05388461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haukeland University Hospital |
| Condition | Depressive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2013-03-13 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2013-03-13 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of the current project is to assess the acute and long term outcome of ECT (both patient and clinician rated) in a non-selected patient cohort from ordinary clinical activity, and to seek out factors predicting response and remission, side effects and relapse.
Eligibility Criteria
Inclusion Criteria: * Patients treated with ECT for major depression (F31.3-5, F32, F33) at Haukeland University Hospital or Stavanger University Hospital after 2013, * written consent to enrolment into the Regional Register for neurostimulation. Exclusion Criteria: * ECT performed on other indications than major depression. * No consent to the register.
Contact & Investigator
Ute Kessler, PhD
✉ ute.kessler@helse-bergen.noFrequently Asked Questions
Who can join the NCT05388461 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05388461 currently recruiting?
Yes, NCT05388461 is actively recruiting participants. Contact the research team at ute.kessler@helse-bergen.no for enrollment information.
Where is the NCT05388461 trial being conducted?
This trial is being conducted at Bergen, Norway, Stavanger, Norway.
Who is sponsoring the NCT05388461 clinical trial?
NCT05388461 is sponsored by Haukeland University Hospital. The trial plans to enroll 600 participants.